PAS 1ml Magtrace® for Sentinel Lymph Node Biopsy in Breast Cancer Patients — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

PAS 1ml Magtrace® for Sentinel Lymph Node Biopsy in Breast Cancer Patients — Stella

Recruiting

Back to Breast Cancer trials

Trial locations(2 sites)

United States

UNC, Lineberger Comprehensive Cancer Center, Chapel Hill, North Carolina

VCU Massey Comprehensive Cancer Center, Richmond, Virginia

Key details

Sponsor

Endomagnetics Ltd.

Collaborators

Endomagnetics Inc

Enrollment target

~184 participants

Started

April 2025

Primary completion

June 2028

Age range

18 Years and older

Last updated March 2026

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.

View full record on ClinicalTrials.gov